The Moderna and Pfizer vaccines have been highly effective at preventing COVID-19. In a new study, researchers looked at the differences in effectiveness between the two vaccines. They found that people who had received two doses of the Moderna vaccine were less likely to develop COVID-19 or become hospitalized with […]
Read More
Summary What is already known about this topic? mRNA COVID-19 vaccines are effective in preventing severe COVID-19. Some studies have shown declines in vaccine effectiveness against severe COVID-19 with increasing time since vaccination. What is added by this report? During February 1–September 30, 2021, mRNA vaccine effectiveness in preventing COVID-19–associated […]
Read More
Vials of the Moderna (R) and Pfizer (L) COVID-19 vaccines.Hazem Bader/AFP via Getty Images Most people who’ve gotten booster shots in the US have stuck with the same brand of vaccine they had initially. But, it’s also fine to switch it up. Some early studies suggest that Moderna’s vaccine is […]
Read More
Seven different COVID-19 vaccines increase immunity when used as a booster for people who have had two doses of AstraZeneca/Oxford vaccine, and 6 vaccines provide immunity as boosters after 2 doses of Pfizer/BioNTech, a study has shown. However there were large variations in antibody and cellular immune responses between vaccines. […]
Read More
Créditos: Comité científico Covid
Read More
La compañía Moderna ha anunciado este lunes que datos provisionales positivos del estudio de fase 2/3 que estudia su vacuna contra la COVID-19 en niños de 6 a menos de 12 años de edad. Este análisis provisional mostró una sólida respuesta de anticuerpos neutralizantes tras dos dosis de la vacuna en dosis de 50 ug, […]
Read More
Moderna announced its COVID-19 mRNA vaccine triggers a strong immune response in children ages 6-11 years, comparable to the boost reported previously in teenagers and adults. These first interim phase 2/3 study results also show the vaccine has a favorable safety profile in this age group. The seroresponse rate of […]
Read More
The COVID-19 pandemic could effectively be over in a year because enough vaccine will be manufactured and distributed by that time, Moderna Chief Executive Stéphane Bancel said in an interview with a Swiss newspaper. “If you look at the industry-wide expansion of production capacities over the past six months, enough […]
Read More
Varios estudios han revelado que, a largo plazo, las dosis de Moderna parecen más efectivas que las de Pfizer-BioNTech. Te decimos por qué. Fue una cantinela constante de las autoridades sanitarias federales en Estados Unidos tras la autorización de las vacunas contra el coronavirus: estas vacunas son todas igual de efectivas.Eso ha […]
Read More
Un estudio dirigido por los Centros para el Control y la Prevención de Enfermedades de EE.UU. (CDC) encontró que la vacuna contra el covid-19 de Moderna es más efectiva contra la hospitalización, pero las de Pfizer y Johnson & Johnson también protegen bien. Un estudio de cabeza a cabeza de las […]
Read More